First Opinion By Muhammad Yunus Preparing for the next pandemic: Time to follow a social business model for patent-free global medicine production
Politics By Rachel Cohrs Biden administration won’t lower seniors’ Medicare premiums this year, despite changes to coverage of new Alzheimer’s drug
Pharmalot By Ed Silverman The World Health Assembly moves to bolster clinical trials, but some say it falls short
Politics By Lev Facher Key Senate committee proposes a council to ensure FDA better coordinates on accelerated approvals
The Readout LOUD By Adam Feuerstein and Meg Tirrell An emergency doctor and parent sorts through Covid vaccine options for kids under 5
Pharmalot By Ed Silverman ViiV will make it easier for generic companies to copy its HIV prevention shot, but it’s not clear when
Don't Miss By Eric Boodman Night sweats, bloody cough — and a diagnosis that turned a doctor into an activist